Life Insurance
Consensus Index

AI Consensus Fit Review

John Hancock Life Insurance Fit Review for Sleep Apnea

John Hancock is a good — but not confirmed best-in-market — fit for a U.S.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

John Hancock is a good — but not confirmed best-in-market — fit for a U.S. buyer with sleep apnea. Four of the seven platforms in this study named John Hancock during ranking discovery, and six of the seven rated it a "good" fit for this use case; one (DeepSeek) rated it "uncertain." The strongest reason to consider it is the combination of fully underwritten term coverage with the Vitality wellness program, which rewards sleep and activity tracking and can reduce premiums by up to 25% [1]. The main limitation is that no platform found a published, sleep-apnea-specific John Hancock underwriting standard, so approval odds and rate class remain case-specific and unverified.

Research Snapshot

FieldValue
Platform mentions in ranking stage4 of 7 platforms
Share of included platform responses57.1%
Average listed rank4.75
Best listed rank4
Relevant product/model/planJohn Hancock term life insurance, including eligible term policies with the John Hancock Vitality PLUS program
Overall use-case fitGood (6 platforms); Uncertain (1 platform) — 7 platforms analyzed
Research date2026-09-22

Why John Hancock Qualified for This Study

Questions This Section Answers

  • Is John Hancock a good choice for life insurance for sleep apnea?
  • Why did AI platforms include John Hancock in a sleep apnea life insurance ranking?

John Hancock qualified because four of the seven platforms named it during ranking discovery, and every platform that evaluated it found a plausible product path for a sleep apnea applicant. The platforms that named it were Anthropic, DeepSeek, Kimi, and Perplexity, with listed ranks of 6, 4, 5, and 4 respectively. The three platforms that did not name it during ranking discovery still evaluated its fit when asked directly.

The qualification rests on three supplied facts. First, John Hancock sells fully underwritten term life insurance, which is the product type most sleep apnea buyers need [3]. Second, eligible policies can include the Vitality program, a wellness and rewards structure tied to health-behavior tracking [4]. Third, independent broker sources describe John Hancock as having been "aggressive" in underwriting for some preexisting conditions, including some sleep apnea cases [6].

No platform found evidence that John Hancock excludes sleep apnea applicants outright [3]. That absence is not proof of acceptance, and it should not be read as one.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Sleep Apnea

Questions This Section Answers

  • Which John Hancock plan should a buyer with sleep apnea choose if they want term coverage plus wellness rewards?
  • Does John Hancock offer a sleep-apnea-specific life insurance product?

The relevant product is John Hancock term life insurance, including eligible term policies with the John Hancock Vitality PLUS program. There is no sleep-apnea-specific John Hancock product, rider, or underwriting credit in the supplied evidence.

Platforms converged on term life as the primary product, with several also naming universal life with Vitality [7]. Term coverage is publicly described as available from $250,000 to $30 million for terms of 10 to 30 years [7]. Universal life is described as available from $50,000 to $65 million [8]. One platform reported that 30-year term is not available in New York [12].

Vitality is the differentiator platforms cited most often. It is described as a wellness program tied to eligible life insurance policies that rewards healthy habits, including sleep-related behavior [13]. One platform reported that all new John Hancock policies are issued with Vitality Go, with eligible customers able to upgrade to Vitality PLUS within 25 months [15]. Other pages describe Vitality as an option on term and permanent products, so the exact current implementation may vary by product, state, or issue date [15].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about John Hancock for sleep apnea life insurance?
  • Is John Hancock's Vitality program relevant to a sleep apnea applicant?

Six of the seven platforms rated John Hancock a "good" fit for this use case; DeepSeek rated it "uncertain." Across those responses, the platforms agreed on four points.

Agreement 1: John Hancock offers a conventional fully underwritten path. Platforms consistently described term life and universal life products that require medical underwriting rather than simplified or guaranteed issue [16]. No platform found a John Hancock simplified-issue or guaranteed-issue product for this use case.

Agreement 2: Vitality is the main differentiator. Platforms agreed that Vitality rewards health behaviors and can produce premium savings of up to 25% with Vitality PLUS [18]. One platform reported that Vitality members can earn up to 900 Vitality Points per year for logging 7 to 9 hours of sleep via compatible devices [21].

Agreement 3: Sleep apnea underwriting is medical and case-specific. Platforms agreed that underwriting considers severity, sleep-study results, CPAP or other treatment compliance, symptoms, weight, and cardiovascular health [22]. No platform found a published John Hancock sleep-apnea rate table.

Agreement 4: Financial strength is not in dispute. Independent reviews cited A+ from AM Best, Aa3 from Moody's, AA- from S&P Global, and AA from Fitch, plus a regulatory complaint record below the industry baseline [25].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • How does John Hancock actually underwrite sleep apnea, and why do AI platforms disagree?
  • Is John Hancock's Vitality PLUS cost included in the premium or charged separately?

The platforms disagreed on how favorable John Hancock actually is for sleep apnea, and they disagreed on the cost structure of Vitality PLUS. Both conflicts are material to a buying decision.

Disagreement 1: Underwriting aggressiveness. Anthropic reported broker evidence that John Hancock has been "very aggressive" for some preexisting conditions including some sleep apnea cases, and cited a case study of a 48-year-old CPAP-compliant applicant with mild sleep apnea who received a Preferred rate offer [28]. Google reported that John Hancock's field guides decline moderate or severe obstructive sleep apnea when combined with conditions such as coronary artery disease, diabetes, obesity, peripheral vascular disease, TIA, valvular heart disease, or alcohol abuse [30]. Google also reported that severe sleep apnea with treatment non-compliance, oxygen use, or respiratory compromise is uninsurable at John Hancock [32]. These findings are not necessarily contradictory — mild controlled cases and severe comorbid cases are different populations — but they describe very different risk postures.

Disagreement 2: Vitality PLUS cost. OpenAI and Perplexity both reported that John Hancock's FAQ states Vitality PLUS costs 3% of annual premium for term policies with the optional Vitality rider [33]. OpenAI also noted that John Hancock's main Vitality page describes Vitality PLUS as included within the cost for certain term products [35]. Anthropic reported that Vitality PLUS cost is included in term policy pricing with no separate add-on fee, while possibly carrying additional cost for permanent policies [36]. The applicable policy illustration and rider form should be treated as controlling.

Uncertainty: CPAP-specific rewards. Kimi reported that the Vitality program specifically rewards CPAP adherence [37]. OpenAI, DeepSeek, and Perplexity each reported that the reviewed public materials do not verify a CPAP-device-data integration or a CPAP-specific underwriting credit [35]. The Vitality sleep feature rewards tracked sleep duration via compatible devices, which is related to but not identical to CPAP compliance [40].

Uncertainty: Express Track eligibility. One platform reported that Express Track is John Hancock's accelerated underwriting program requiring no in-person medical exam for qualifying applicants [42]. The same platform noted that Express Track availability for sleep apnea applicants is not explicitly confirmed and that standard medical underwriting may override acceleration [42].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does John Hancock offer that matter to a sleep apnea life insurance buyer?
  • Does John Hancock's Vitality program track CPAP data or only general sleep and activity?

The features most relevant to a sleep apnea buyer are the fully underwritten term structure, the Vitality rewards program, and the coverage range. None of them is sleep-apnea-specific.

Fully underwritten term coverage. John Hancock term life is publicly described with 10-, 15-, 20-, and 30-year term options [43]. Coverage ranges from $250,000 to $30 million [44]. Universal life is described from $50,000 to $65 million [46].

Vitality rewards. John Hancock states that Vitality rewards healthy activities and may provide premium savings of up to 25% with Vitality PLUS, subject to underwriting status, policy type, Vitality status, and policy terms [48]. Premium savings are described as cumulative and variable based on underwriting status, issue age, policy type, and Vitality Status [49]. Savings are only available with Vitality PLUS and may not apply to all products [50].

Sleep and activity tracking. Vitality members can earn points for 7 to 9 hours of sleep tracked with compatible devices, up to 900 points per year, or through Sleep Well Challenges [51]. One independent source reported that an Oura Ring can track hours of sleep and mindfulness to earn Vitality points [53]. Vitality PLUS members can access Apple Watch models, including Series 10 with sleep apnea notifications, starting at $25 [54]. One platform reported that Vitality PLUS customers make an initial payment of $25 and can reduce remaining monthly device payments to $0 through regular activity [55].

Exam cost subsidy. One platform reported that for eligible policies with face amounts of $500,000 or greater, 100% of the cost of the test will be subsidized [56].

What is not documented. No platform found a John Hancock CPAP-device-data integration, a CPAP-adherence reward, or a sleep-apnea-specific underwriting credit [48]. CPAP compliance tracking appears to rely on applicant self-reporting or physician documentation rather than direct machine-data integration [59].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does John Hancock term life insurance cost per month for a 40-year-old nonsmoker?
  • Is Vitality PLUS worth the cost for a sleep apnea buyer, and what happens if engagement lapses?

No sleep-apnea-specific John Hancock premium is published in the supplied evidence. General pricing benchmarks exist, but they do not reflect a sleep apnea rating.

Base premium benchmarks. One independent review reported that a $100,000 John Hancock term policy costs $9 per month for women and $11 per month for men, for a 40-year-old nonsmoker with a 20-year term [60]. The same source reported John Hancock pricing at 40–43% below the national average for that profile [61]. Another source reported that following early 2026 term rate reductions averaging 13% for ages 35–60, John Hancock's average premium runs 9% below the industry average [62]. These figures describe standard health profiles, not sleep apnea cases.

Vitality GO. Described by John Hancock as automatically included with eligible policies at no additional cost, subject to availability [65].

Vitality PLUS. John Hancock's FAQ states a cost of 3% of annual premium for term policies with the optional Vitality rider [65]. John Hancock's consumer Vitality page also states that cost treatment can vary by product, and one platform reported Vitality PLUS as included in term policy pricing with no separate add-on fee [68]. The policy illustration should control.

Device costs. Vitality PLUS members opting into the Apple Watch hardware reward program make an initial payment of $25 plus tax, with remaining monthly device payments reducible to $0 through regular activity [70].

Medical underwriting costs. Attending Physician Statement fees may apply, with excess over $100 requiring pre-approval; medical exam and lab work fees apply; policy riders add cost [72].

Contract terms. Term coverage ends or requires renewal or conversion according to the policy contract, and exact conversion rights and renewal pricing must be confirmed [65]. Vitality rewards, discounts, eligibility, and benefits are subject to change and are not guaranteed for the life of the policy [68]. If Vitality engagement lapses, savings reduce [75].

Pricing confidence is low. No individualized premium can be verified without age, sex, state, coverage amount, term length, tobacco status, sleep apnea severity, treatment history, and full underwriting [65]. The advertised up-to-25% Vitality PLUS savings is conditional and is not a sleep apnea discount [68].

Best Suited For

Questions This Section Answers

  • Who is John Hancock best suited for among sleep apnea life insurance buyers?
  • Is John Hancock a good fit for a CPAP-compliant applicant with mild to moderate sleep apnea?

John Hancock is best suited for a buyer with documented, treated, and stable sleep apnea who is willing to complete full medical underwriting and who values a wellness rewards program.

Platforms identified these buyer profiles as the strongest fit:

  • Applicants with mild-to-moderate, well-controlled obstructive sleep apnea who are actively using CPAP with documented compliance [77].
  • Health-conscious buyers willing to track and report wellness activities to earn Vitality rewards [80].
  • Buyers who want premium reduction through behavioral incentives aligned with CPAP adherence [82].
  • Consumers aged 35–60 who may benefit from the early 2026 term rate reductions [83].
  • Applicants who want to compare a traditional fully underwritten offer against other carriers rather than relying only on simplified issue [85].

One platform reported that John Hancock can offer Standard to Preferred rates for applicants with mild-to-moderate obstructive sleep apnea who are non-smokers, fully compliant with CPAP or other prescribed treatments, and have no rateable build [86]. That finding comes from underwriting guide material, not from a current John Hancock rate manual, and should be verified.

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose John Hancock for life insurance with sleep apnea?
  • Does John Hancock decline life insurance applicants with severe sleep apnea and heart conditions?

John Hancock is probably not the best fit for applicants with untreated, severe, or non-compliant sleep apnea, or for buyers who do not want ongoing health tracking.

Platforms identified these exclusion profiles:

  • Applicants with untreated or undiagnosed sleep apnea [87].
  • Individuals with severe sleep apnea (AHI 30+) without long-term treatment compliance documentation [87].
  • Applicants with moderate or severe obstructive sleep apnea combined with coronary artery disease, diabetes, obesity, peripheral vascular disease, TIA, valvular heart disease, or alcohol abuse, which one platform reported as a decline under John Hancock guidelines [90].
  • Applicants with severe sleep apnea plus treatment non-compliance, oxygen use, or respiratory compromise or failure, which one platform reported as uninsurable at John Hancock [92].
  • Applicants seeking guaranteed-issue or simplified-issue policies, since John Hancock requires medical underwriting [93].
  • Buyers who do not want health data collection, activity tracking, variable rewards, or program-related conditions [95].
  • Applicants who need whole life insurance, which one platform reported John Hancock does not offer [87].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to John Hancock for a sleep apnea buyer who wants the lowest base premium?
  • When should a sleep apnea applicant choose a simplified-issue carrier instead of John Hancock?

Another option may be better in five situations. Each is drawn from platform-reported alternatives, and none of the named alternatives was independently verified in this study.

When the buyer wants the lowest base premium without a wellness program. Platforms named Banner Life for term coverage up to age 55 and Prudential for mild-to-moderate treated cases as alternatives [97]. One platform reported that Prudential historically allows Preferred rates for mild apnea with documented treatment when other carriers cap at Standard Plus [97].

When the buyer needs no-exam or simplified issue. Platforms named Mutual of Omaha, AIG, and Fidelity Life products as simplified-issue alternatives [97]. One platform noted that simplified-issue policies may cost more or offer less coverage [98].

When the apnea is severe, unstable, or accompanied by serious cardiovascular disease. Platforms recommended shopping with carriers known for broader impaired-risk pricing, naming Zurich Life, Prudential, and Mass Mutual per broker testing [99]. One platform named Protective Life for explicitly documented preferred rates for treated moderate-to-severe apnea [100].

When the buyer needs guaranteed acceptance. Platforms recommended final expense or guaranteed acceptance carriers for severe untreated apnea [97].

When the buyer does not want to share ongoing health data. Platforms recommended traditional fully underwritten products from Protective, Pacific Life, or others [97]. One independent reviewer noted that if tracking requirements feel burdensome, applicants may find better value in straightforward policies from another provider [101].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with John Hancock before signing a sleep apnea life insurance contract?
  • What CPAP compliance documentation does John Hancock require during underwriting?

These questions come directly from the platform responses and should be answered in writing before an application is submitted.

  • Will the application be eligible for accelerated underwriting, or will sleep apnea require an exam, sleep-study records, CPAP compliance data, or physician records [102]?
  • How will apnea-hypopnea index, oxygen desaturation, diagnosis date, treatment type, CPAP adherence, residual AHI, symptoms, BMI, and cardiovascular history affect eligibility and rate class [104]?
  • Does John Hancock accept CPAP-machine compliance reports, and what minimum adherence period or usage level is required [106]?
  • Is Vitality PLUS available with the exact term product, face amount, state, and policy form being quoted [107]?
  • Is the Vitality charge 3% of annual premium, included in the base premium, or otherwise calculated for the exact policy [108]?
  • Are Vitality savings guaranteed, and what happens to premiums if Vitality status falls or the program changes [110]?
  • What are the guaranteed renewal, conversion, cancellation, contestability, and policy-lapse terms [108]?
  • Can an independent broker obtain preliminary informal underwriting before a formal application and preserve the ability to compare other carriers [102]?
  • How does John Hancock underwrite central sleep apnea or complex apnea with cardiac or neurologic causes [112]?
  • Is the desired policy type and term length available in the buyer's state [113]?

Final AI Consensus Verdict

John Hancock is a good, conditional fit for life insurance with sleep apnea, not a confirmed best-in-market choice. Six of seven platforms rated it good; one rated it uncertain. The strongest supported reason to consider it is the combination of fully underwritten term coverage with a wellness program that rewards sleep and activity tracking and can reduce premiums by up to 25% [115]. The decisive unknown is John Hancock's case-specific underwriting treatment of sleep apnea, which no platform found published. Buyers should obtain an informal multi-carrier underwriting comparison before applying, and should treat the policy illustration and rider form as controlling on Vitality cost.

How This Review Was Produced

This review was produced from seven AI platform responses collected for the topic "Best Life Insurance for Sleep Apnea" with a research date of 2026-09-22. Each platform was asked which life insurance carriers are generally worth considering for applicants with sleep apnea and why. Four of the seven platforms named John Hancock during ranking discovery; all seven evaluated its fit when asked directly. The ranking statistics, fit ratings, product mappings, pricing details, and verification questions in this review come from those platform responses and their cited sources. No independent testing, customer experience, or medical benefit was assessed. Platform-reported claims are labeled as such where the supplied evidence did not include a citation.

Methodology Limitations

Several limitations apply to this review.

No published sleep-apnea-specific underwriting standard. No platform found a current John Hancock rate manual, impairment guide, or public page stating how CPAP adherence, apnea-hypopnea index, sleep-study results, oxygen desaturation, obesity, or cardiovascular comorbidities are rated [117].

Conflicting Vitality PLUS cost descriptions. John Hancock's FAQ states 3% of annual premium for term policies with the optional rider, while its main Vitality page describes Vitality PLUS as included within the cost for certain term products [120]. One platform reported it as included with no separate add-on fee for term [123].

Conflicting underwriting posture. One platform reported broker evidence of aggressive underwriting and a Preferred-rate case study for mild controlled apnea [124], while another reported decline criteria for moderate or severe apnea with comorbidities and uninsurability for severe non-compliant cases [126].

Unverified CPAP reward claim. One platform stated that Vitality specifically rewards CPAP adherence [129], while three others reported that public materials do not confirm a CPAP-device-data integration or CPAP-specific credit [121].

Platform research date discrepancy. DeepSeek's platform-reported research date was 2026-05-19, while the authoritative run research date and the other six platforms' dates were 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

No-search model. DeepSeek reported search_enabled as false, so its claims are model-reported rather than retrieved from live sources.

Unvalidated URLs. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. One official-site retrieval attempt for johnhancock.com returned HTTP 403 and was not used as a verified source.

Identity verification. The deterministic identity audit used exact-name fallback, and the matching reported domain was retained for downstream research but remains unverified.

No quality inference. Platform agreement does not prove product quality, approval odds, or premium outcomes for any individual applicant.

Sources

Company-Owned Sources

Independent Sources

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
46
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#7

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

31 independent · 15 company-owned

Evidence support

35 direct · 11 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

61d2b73f42d4a72eec7e739f4d5abf881f1bfa0d079b7011de33ca99756bf9b5